FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 301 through 321 of 321

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
VIVS Nasdaq VivoSim Labs, Inc. 2836
VOR Nasdaq Vor Biopharma Inc. 2836
VRDN Nasdaq Viridian Therapeutics, Inc. 2836
VRTX Nasdaq Vertex Pharmaceuticals Incorporated 2836
VRXA Nasdaq Veraxa Biotech AG 2836
VSTM Nasdaq Verastem, Inc. 2836
VTRLY Over the counter Vitrolife AB (publ) 2836
VTVT Nasdaq vTv Therapeutics Inc. 2836
VYGR Nasdaq Voyager Therapeutics, Inc. 2836
VYLR New York Vylor Inc. 2836
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2836
XTLB Nasdaq XTL Biopharmaceuticals Ltd. 2836
ZBIO Nasdaq Zenas BioPharma, Inc. 2836
ZEOX Over the counter Zeo ScientifiX, Inc. 2836
ZLAB Nasdaq Zai Lab Limited 2836
ZLDPY Over the counter Zealand Pharma A/S 2836
ZNTL Nasdaq Zentalis Pharmaceuticals, Inc. 2836
ZSQR Nasdaq Z Squared Inc. 2836
ZTS New York Zoetis Inc. 2836
ZURA Nasdaq Zura Bio Limited 2836
ZYME Nasdaq Zymeworks Inc. 2836
Results 300 through 321 of 321